Fast Five Quiz: Pediatric Atopic Dermatitis

Dirk M. Elston, MD


June 07, 2021

Wet dressings, or wet-wrap therapy (WWT), are useful for acute AD flares in patients with moderate to severe AD whose disease has not responded to standard treatments. WWT improves barrier function and increases the effect of topical calcineurin therapy. WWT is typically performed for 5-7 days to control a severe AD flare; chronic use of WWT is not recommended. Consultation with a specialist is recommended before initiation of this therapy.

Topical corticosteroids are the first line of treatment in AD.

Crisaborole, a phosphodiesterase 4 inhibitor, is approved for children and can be used in mild to moderate AD.

Recurrent use of oral corticosteroids is not recommended as a treatment for pediatric AD owing to side effects, including stunted growth.

Learn more about AD medication.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.